UTI Statistics
Total Valuation
UTI has a market cap or net worth of $1.40 billion. The enterprise value is $1.48 billion.
| Market Cap | 1.40B |
| Enterprise Value | 1.48B |
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
UTI has 54.37 million shares outstanding. The number of shares has increased by 57.06% in one year.
| Current Share Class | 54.37M |
| Shares Outstanding | 54.37M |
| Shares Change (YoY) | +57.06% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 2.67% |
| Owned by Institutions (%) | 77.24% |
| Float | 47.77M |
Valuation Ratios
The trailing PE ratio is 26.43 and the forward PE ratio is 30.19. UTI's PEG ratio is 1.98.
| PE Ratio | 26.43 |
| Forward PE | 30.19 |
| PS Ratio | 1.80 |
| Forward PS | 1.63 |
| PB Ratio | 4.92 |
| P/TBV Ratio | 5.87 |
| P/FCF Ratio | 18.45 |
| P/OCF Ratio | 13.97 |
| PEG Ratio | 1.98 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.44, with an EV/FCF ratio of 19.98.
| EV / Earnings | 27.59 |
| EV / Sales | 1.95 |
| EV / EBITDA | 14.44 |
| EV / EBIT | 20.49 |
| EV / FCF | 19.98 |
Financial Position
The company has a current ratio of 1.14, with a Debt / Equity ratio of 1.02.
| Current Ratio | 1.14 |
| Quick Ratio | 0.99 |
| Debt / Equity | 1.02 |
| Debt / EBITDA | 1.85 |
| Debt / FCF | 3.86 |
| Interest Coverage | 8.75 |
Financial Efficiency
Return on equity (ROE) is 21.41% and return on invested capital (ROIC) is 7.96%.
| Return on Equity (ROE) | 21.41% |
| Return on Assets (ROA) | 6.09% |
| Return on Invested Capital (ROIC) | 7.96% |
| Return on Capital Employed (ROCE) | 13.13% |
| Revenue Per Employee | $205,249 |
| Profits Per Employee | $14,531 |
| Employee Count | 3,700 |
| Asset Turnover | 1.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, UTI has paid $16.45 million in taxes.
| Income Tax | 16.45M |
| Effective Tax Rate | 23.42% |
Stock Price Statistics
The stock price has increased by +58.22% in the last 52 weeks. The beta is 1.49, so UTI's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | +58.22% |
| 50-Day Moving Average | 27.24 |
| 200-Day Moving Average | 21.10 |
| Relative Strength Index (RSI) | 40.87 |
| Average Volume (20 Days) | 823,487 |
Short Selling Information
The latest short interest is 2.05 million, so 3.76% of the outstanding shares have been sold short.
| Short Interest | 2.05M |
| Short Previous Month | 1.77M |
| Short % of Shares Out | 3.76% |
| Short % of Float | 4.28% |
| Short Ratio (days to cover) | 2.57 |
Income Statement
In the last 12 months, UTI had revenue of $759.42 million and earned $53.77 million in profits. Earnings per share was $0.97.
| Revenue | 759.42M |
| Gross Profit | 419.63M |
| Operating Income | 72.38M |
| Pretax Income | 40.10M |
| Net Income | 53.77M |
| EBITDA | 102.72M |
| EBIT | 72.38M |
| Earnings Per Share (EPS) | $0.97 |
Balance Sheet
The company has $172.57 million in cash and $286.16 million in debt, giving a net cash position of -$113.59 million or -$2.09 per share.
| Cash & Cash Equivalents | 172.57M |
| Total Debt | 286.16M |
| Net Cash | -113.59M |
| Net Cash Per Share | -$2.09 |
| Equity (Book Value) | 279.98M |
| Book Value Per Share | 5.15 |
| Working Capital | 28.52M |
Cash Flow
In the last 12 months, operating cash flow was $98.02 million and capital expenditures -$23.80 million, giving a free cash flow of $74.23 million.
| Operating Cash Flow | 98.02M |
| Capital Expenditures | -23.80M |
| Free Cash Flow | 74.23M |
| FCF Per Share | $1.37 |
Margins
Gross margin is 55.26%, with operating and profit margins of 9.53% and 7.08%.
| Gross Margin | 55.26% |
| Operating Margin | 9.53% |
| Pretax Margin | 9.25% |
| Profit Margin | 7.08% |
| EBITDA Margin | 13.53% |
| EBIT Margin | 9.53% |
| FCF Margin | 9.77% |
Dividends & Yields
UTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -57.06% |
| Shareholder Yield | -57.06% |
| Earnings Yield | 3.93% |
| FCF Yield | 5.42% |
Analyst Forecast
The average price target for UTI is $31.17, which is 21.05% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $31.17 |
| Price Target Difference | 21.05% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
UTI has an Altman Z-Score of 2.63 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.63 |
| Piotroski F-Score | 8 |